SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

After a significant dip attributed to broader AI sector concerns and potential overreactions to $ORCL news, $CRWV is seeing active debate about its oversold condition and potential for a rebound. The community is closely watching for a recovery, fueled by its strong backlog and Nvidia's involvement, while also considering factors like insider selling and convertible debt. Discussions range from potential short squeezes to long-term bullish perspectives on AI infrastructure.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as the company tests driverless cars in Austin, leading to speculation about full autonomy and future robotaxi services. The community is actively discussing the implications of this technology and potential impact on Tesla's valuation, with some pointing to high P/E ratios. Bullish sentiment is fueled by the possibility of new highs and a 'Santa Claus rally,' while bears express concerns about overvaluation and market manipulation.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending as traders assess its recent price drop amid concerns about AI infrastructure spending and potential rate hikes. Community discussions range from short-term bearish sentiment and technical analysis to long-term bullish outlooks based on the company's fundamentals and contracted revenue. Investors are weighing the impact of potential AI bubble concerns against IREN's growth prospects and existing deals.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

RKLB is trending due to a mix of factors including a recently aborted launch, planned share sales by Peter Beck, and broader tech sector volatility, leading to community discussion about short-term turbulence versus long-term potential. Despite these headwinds, many investors express confidence in the company's fundamentals and future growth, particularly related to the Neutron rocket and potential government contracts. The stock's movement is also influenced by speculation around a potential SpaceX IPO and its impact on the space sector.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals ($CRML) is trending amid discussions about rare earth element (REE) needs for military applications and reactions to recent drilling results from the Tanbreez Rare Earth Project. Community members are weighing the significance of these results and pondering the potential for future growth. Some are speculating on the impact of potential government investment and partnerships, while others express skepticism about the company's progress and the overall market's valuation of REE assets.

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMCI is trending due to its explosive move and after-hours continuation, with community members actively discussing potential price targets and the possibility of a short squeeze. The stock, a robotics de-SPAC, is garnering attention despite sector challenges, with some drawing parallels to previous high-flying stocks and anticipating further gains. Traders are closely monitoring key resistance levels and potential breakout points.

$WORKIE is the official workers memecoin on Base.

Workie

Workie crypto is trending with increased community interest, indicated by repetitive mentions of the ticker. Speculation is building around potential catalysts for the token. The community appears to be coalescing around a bullish outlook.

Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is founded by Paul A. Hopper in 2021 headquartered Carlton, Australia.

Radiopharm Theranostics Ltd - ADR

RADX is trending due to significant intraday volatility following positive Phase 2b trial data, leading to discussions about potential short squeezes and the company's financial stability. Community chatter revolves around high trading volume, potential price targets, and whether the stock is overvalued or poised for further gains based on its therapeutic pipeline. The stock's webinar presentation is also a key point of discussion, with investors looking for further catalysts.

Mask Network is the core product of Dimension, which is positioned to become the bridge that connects internet users from Web 2.0 to Web 3.0. The foundational technology of Mask Network is a peer-to-peer encrypted messaging application, with new functions continuously being created around this foundation. We at Mask Network are strong believers in the ownership economy. People should own what they produce, people should own their data, their attention and the virtual space they choose to contribute to.  Mask Network integrates decentralized social messaging, borderless payment network, and decentralized file storage and sharing to provide a safe and convenient portal for users to jump right into the continent of decentralized finance and then the new world of Web 3.0.

Mask Network

MASK is trending as community members discuss its potential as an AI stock, drawing comparisons to previous runners. Positive news and a low float are contributing to the bullish sentiment, with some anticipating a continued uptrend. Chatter revolves around potential price targets, but is mostly very speculative.

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Nektar Therapeutics

Nektar Therapeutics is trending as investors anticipate topline results from its Phase 2b study of Rezpegaldesleukin for alopecia areata, expected soon. The community is highly focused on the upcoming data, with some speculating on the potential impact on the stock price based on different outcomes. Discussions also include potential settlement outcomes from their lawsuit with Eli Lilly, adding another layer of speculation to the stock's movement.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>On Friday, CNBC reported that an executive order could come as soon as Monday, causing a significant surge in cannabis stocks during the Friday trading session.</li><li>The rally didn't hold on Monday as investors cashed in on the Friday gains.&nbsp;</li><li>Marijuana remains a Schedule I drug under federal law — the same category as heroin and LSD — a classification reserved for substances deemed to have high abuse potential and no accepted medical use. &nbsp;</li></ul>Cannabis stocks had a volatile session on Monday after President Trump said that he is “strongly” looking at an executive order directing federal agencies to reclassify marijuana as a less dangerous drug."We are considering that. Because a lot of people want to see it," Trump said during a Mexican Border Defense medal presentation at the White House in Washington, DC. "The reclassification, because it leads to tremendous amounts of research that can’t be done unless you reclassify. So we are looking at that very strongly."<h2 class="st-heading-2">Trump’s Reaffirmation Fails To Sustain Second Day Of Rally</h2>Trump first hinted at reclassifying marijuana as a less dangerous drug in August. On Wednesday, Trump reportedly discussed the plan with House Speaker Mike Johnson, a Republican, in a call that also included marijuana industry executives, Health Secretary Robert F. Kennedy Jr., and CMS chief Mehmet Oz.The president is expected to seek to ease access to the drug through an upcoming executive order that directs federal agencies to pursue reclassification, the Washington Post reported on Thursday, citing unnamed sources. The move might not legalize or decriminalize marijuana, but it would ease barriers to research, the report said.On Friday, CNBC reported that an executive order could come as soon as Monday, causing a <a href="https://stocktwits.com/news-articles/markets/equity/tilray-canopy-growth-sndl-soar-on-hopes-trump-will-reclassify-marijuana-on-monday/cLICDZhRE8W">significant surge</a> in cannabis stocks during the Friday trading session. However, the rally didn't hold on Monday as investors cashed in on the Friday gains.On Monday, <a href="https://stocktwits.com/symbol/TLRY">Tilray stock</a> closed down 10% and edged up 3% after hours, while <a href="https://stocktwits.com/symbol/CGC">Canopy Growth</a> stock closed 5% lower. Shares of cannabis retailer <a href="https://stocktwits.com/symbol/SNDL">SNDL</a>, meanwhile, closed down 13% in the regular trading session and gained 2% after hours.<h2 class="st-heading-2">Current Classification</h2>Marijuana remains a Schedule I drug under federal law — the same category as heroin and LSD — a classification reserved for substances deemed to have high abuse potential and no accepted medical use.Trump is expected to classify marijuana as a Schedule III substance, indicating that it has a lesser potential for abuse and is allowed for use in specific medical treatments, but can also create risks of physical or psychological dependence.Other Schedule III drugs include Tylenol with codeine, as well as specific steroid and hormone treatments.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around TLRY and CGC are trending in the ‘extremely bullish’ territory, coupled with ‘extremely high’ message volume.While TLRY stock has dropped 18% this year, CGC has lost 39%.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/elon-musk-becomes-first-person-ever-worth-600-billion-dollars-widens-lead-over-larry-page/cLe4i4BREoH">Elon Musk Becomes First Person Ever Worth $600B — Widens Lead Over Larry Page As Trillionaire Milestone Nears</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Legalized Marijuana In Canada (Photo by Lane Turner/The Boston Globe via Getty Images)

Cannabis Stocks Lose Their High As Profit-Taking Kicks In Despite Trump’s Reclassification Talk

Trump said that he is looking “very strongly” into reclassifying marijuana to aid research. 

Equity

Trump said that he is looking “very strongly” into reclassifying marijuana to aid research. 


SNDL (NASDAQ:SNDL) Shares Gap Up - Time to Buy?

SNDL (NASDAQ:SNDL) Shares Gap Up - Time to Buy...

SNDL Target of Unusually Large Options Trading (NASDAQ:SNDL)

SNDL Inc. (NASDAQ:SNDL - Get Free Report) was the target of unusually large options trading activity on Friday. Stock traders bought 8,621 call options on the company. This is an increase of 141...

<ul class="summary-bullets"><li>Trump first hinted at reclassifying marijuana as a less dangerous drug in August.</li><li>The president is expected to seek to ease access to the drug through an upcoming executive order that directs federal agencies to pursue reclassification, the Washington Post reported on Thursday.&nbsp;</li><li>Marijuana remains a Schedule I drug under federal law — the same category as heroin and LSD.</li></ul>Shares of Cannabis stocks Tilray (TLRY), Canopy Growth (CGC) and others soared on Friday following a media report that the White House is expected to ease federal restrictions on marijuana as soon as Monday.While shares of Tilray closed 44% higher on Friday, Canopy Growth stock closed 54% higher. Shares of SNDL Inc (SNDL) gained 25%.According to a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.cnbc.com/2025/12/12/cannabis-stocks-trump-regulations.html?__source&amp;#61;newsletter%7Cbreakingnews">report</a> from CNBC, citing an unnamed person familiar with the matter, President Trump is expected to issue an executive order as soon as Monday allowing for reclassification of marijuana.Trump first hinted at reclassifying marijuana as a less dangerous drug in August. On Wednesday, Trump <a href="https://stocktwits.com/news-articles/markets/equity/trump-moves-a-step-closer-to-reclassifying-marijuana-as-a-less-dangerous-drug-a-breakout-moment-for-weed-industry/cLICa8WREFB">reportedly</a> discussed the plan with House Speaker Mike Johnson, a Republican, in a call that also included marijuana industry executives, Health Secretary Robert F. Kennedy Jr., and CMS chief Mehmet Oz.The president is expected to seek to ease access to the drug through an upcoming executive order that directs federal agencies to pursue reclassification, the Washington Post reported on Thursday, citing unnamed sources. The move might not legalize or decriminalize marijuana, but it would ease barriers to research, the report said.<h2 class="st-heading-2">Current Classification</h2>Marijuana remains a Schedule I drug under federal law — the same category as heroin and LSD — a classification reserved for substances deemed to have high abuse potential and no accepted medical use.Trump is expected to classify marijuana as a Schedule III substance, indicating that it has a lesser potential for abuse and is allowed for use in specific medical treatments, but can also create risks of physical or psychological dependence.Other Schedule III drugs include Tylenol with codeine, as well as specific steroid and hormone treatments.However, according to <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.forbes.com/sites/willyakowicz/2025/12/11/white-house-says-president-trump-has-made-no-final-decisions-around-marijuana-rescheduling/">Forbes</a>, a White House official said that “no final decisions have been made on the rescheduling of marijuana.”<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around TLRY and <a href="https://stocktwits.com/symbol/CGC">CGC </a>are trending in the ‘extremely bullish’ territory, coupled with ‘extremely high’ message volume.While <a href="https://stocktwits.com/symbol/TLRY">TLRY stock</a> has dropped 9% this year, CGC has lost 37%.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/anavex-stock-slides-after-hours-on-ema-panels-negative-alzheimers-drug-opinion/cLICvddRE8X">Anavex Stock Slides After Hours On EMA Panel’s Negative Alzheimer’s Drug Opinion — Retail Traders Talk Buyout Potential</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

So far this year, ACB is up 5.4%, CGC is down 54.4%, CRON is up 13.9% and TCNNF is up 10.5%. (Photo credit: Getty Images)

Tilray, Canopy Growth And SNDL Soar On Hopes Trump Will Reclassify Marijuana On Monday

President Trump is reportedly expected to issue an executive order as soon as Monday allowing for reclassification of marijuana. 

Best Cannabis Stocks To Keep An Eye On - December 12th

Tilray Brands, Canopy Growth, RYTHM, Akanda, Cronos Group, Aurora Cannabis, and SNDL are the seven Cannabis stocks to watch today, according to MarketBeat's stock screener tool. Cannabis stocks are...

Cannabis stocks surge on report Trump seeks to ease restrictions

Shares of cannabis companies jumped on Friday after the Washington Post reported U.S. President Donald Trump is expected to push the government to dramatically loosen federal restrictions on...

Cannabis Stocks To Follow Today - December 11th

Tilray Brands, Canopy Growth, Cronos Group, Aurora Cannabis, SNDL, Quantum Biopharma, and Organigram Global are the seven Cannabis stocks to watch today, according to MarketBeat's stock screener...

Top Cannabis Stocks To Follow Today - December 9th

Tilray Brands, Cronos Group, Canopy Growth, Aurora Cannabis, and SNDL are the five Cannabis stocks to watch today, according to MarketBeat's stock screener tool. Cannabis stocks are shares of...

Cannabis Stocks To Follow Now - December 8th

Tilray Brands, Canopy Growth, Greenlane, Aurora Cannabis, Akanda, Cronos Group, and SNDL are the seven Cannabis stocks to watch today, according to MarketBeat's stock screener tool. Cannabis stocks...

Promising Cannabis Stocks To Follow Today - December 4th

Tilray Brands, Canopy Growth, Aurora Cannabis, Flora Growth, and SNDL are the five Cannabis stocks to watch today, according to MarketBeat's stock screener tool. Cannabis stocks are publicly traded...

SNDL, Inc. is a licensed producer that crafts small-batch cannabis using state-of-the-art indoor facilities. It operates through the following segments: Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments. The Liquor Retail segment consists of wines, beers, and spirits through owned liquor stores. The Cannabis Retail segment comprises of the private sale of adult-use cannabis through owned and franchise retail cannabis stores. The Cannabis Operations covers the cultivation, distribution and sale of cannabis for the adult-use, and medical markets domestically and for export. The Investments segment includes the deployment of capital to investment opportunities. The company was founded by Stanley J. Swiatek on August 19, 2006 and is headquartered in Calgary, Canada.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$0.01	--	--	N/A
Q3 '25	-$0.00	-$0.04	-10096.53%	MISSED
Q2 '25	-$0.04	$0.01	119.50%	BEAT
Q1 '25	-$0.06	-$0.04	26.27%	BEAT
Q4 '24	-$0.01	-$0.01	-0.77%	MISSED

SNDL
Sundial Growers Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest SNDL News

SNDLSundial Growers Inc